Testimony to the FDA’s Advisory Committee on Reproductive Health Drugs on Nasal Calcitonin for Osteoporosis
March 5, 2013
View as PDF.
View press release
Calcitonin nasal spray, prescribed to treat osteoporosis since 1994, should be removed from the market because it is not very effective for preventing fractures and may cause cancer and other serious side effects.